Merck Explores KRAS Inhibitors with US$2.55 B Taisho/Astex Deal

By Michelle Liu

Pharma Deals Review: Vol 2020 Issue 1 (Table of Contents)

Published: 11 Jan-2020

DOI: 10.3833/pdr.v2020.i1.2497     ISSN: 1756-7874

Section: Research & Development



Starting the new year off with a bang, Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details